Ara
Toplam kayıt 12, listelenen: 1-10
OSTEOPROTEGERIN PLASMA CONCENTRATIONS ARE CORRELATED WITH FORCED EXPIRATORY VOLUME AT 1 SECOND (FEV1) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
(European Respiratory Soc Journals Ltd, 2013)
[No Abstract Available]
Osteoprotegerin Plasma Concentrations Are Correlated with Forced Expiratory Volume At 1 Second (Fev1) in Patients with Chronic Obstructive Pulmonary Disease
(Carbone Editore, 2015)
Introduction: Several inflammatory biomarkers such as 1L-1 beta, IL-6 and TNF-alpha have been evaluated during stable state and exacerbations of chronic obstructive pulmonary disease (COPD), Osteoprotegerin (OPG) is a ...
Purine Catabolic Enzymes and Nitric Oxide in Patients with Iron Deficiency Anemia
(Carbone Editore, 2014)
Introduction: To clarify the mechanism of oxidative damage,which affects many tissues and organ systems in iron deficiency anemia, comes into prominence in the treatment and avoiding the complications of the disease. In ...
Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS)
(Springer London Ltd, 2016)
Various types of disease activity measures are available for axial spondyloarthritis (axSpA), and there is no gold standard for all individual patients. The ankylosing spondylitis disease activity score (ASDAS) is highly ...
Ccr2 Expression Was Increased in Patients with Ankylosing Spondylitis Independent From Disease Activity
(Bmj Publishing Group, 2015)
[No Abstract Available]
Prevalence of Irritable Bowel Syndrome in Patients with Ankylosing Spondylitis
(Bmj Publishing Group, 2015)
[No Abstract Available]
Performance Characteristics of Simplified Version of Ankylosing Spondylitis Disease Activity Score (SASDAS) and Other Activity Index
(Bmj Publishing Group, 2015)
[No Abstract Available]
Vitamin D Deficiency Might Contribute Fatigue and Disease Activity in Patients with Fibromyalgia
(Bmj Publishing Group, 2015)
[No Abstract Available]
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
(Springer, 2021)
Background The new second-generation tyrosine kinase inhibitors (TKIs) have superior survival outcome and worse toxicity profile when compared with first-generation TKIs according to the results of clinical trials. However, ...
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
(Lippincott Williams & Wilkins, 2022)
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...